Streetbeat News

Earnings

XENE

Xenon Pharmaceuticals' stock is up following positive topline results from their Phase 2 X-NOVA clinical trial of XEN1101 in Major Depressive Disorder (MDD).

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 3:02 pm

THAR

Tharimmune Inc (NASDAQ:THAR) reported positive Phase 1 data for TH104, a transmucosal buccal film, showing higher bioavailability and similar pharmacokinetics compared to a European tablet. The studies indicated potential benefits for patients with impaired liver function and consistent safety profiles. The company plans to discuss Phase 2 trial design with the FDA and expects topline data in 2024 for treating chronic pruritis in primary biliary cholangitis patients. THAR's stock price surged 50% to $4.32.

Portfolio Pulse from Vandana Singh

November 27, 2023 | 3:01 pm

SPY

October's new home sales were reported at 679K, falling short of the estimated 721K. This indicates a potential slowdown in the housing market, which could impact related sectors and stocks.

Portfolio Pulse from Bill Haddad

November 27, 2023 | 3:00 pm

ITRN

Ituran Location And Control's stock is trading higher following the announcement of their Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 2:58 pm

AVXL

Anavex Life Sciences' stock price has declined following the release of their Q4 financial results.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 2:56 pm

BDRX

BGLC

IMPL

PRQR

RDHL

SHOP

THAR

U.S. stocks opened lower on Monday, with the Dow Jones down by over 50 points. Shopify Inc (SHOP) reported a record $4.1 billion in Black Friday sales, a 22% increase from last year. RedHill Biopharma (RDHL), Biodexa Pharmaceuticals (BDRX), and Tharimmune (THAR) saw their stocks surge on positive news, while BioNexus Gene Lab (BGLC), Impel Pharmaceuticals (IMPL), and ProQR Therapeutics (PRQR) experienced declines. Oil prices dipped slightly, while gold and silver saw gains.

Portfolio Pulse from Lisa Levin

November 27, 2023 | 2:46 pm

THAR

Tharimmune shares have seen an increase in trading activity following the announcement of positive Phase 1 data for their drug TH104. This development could potentially lead to further clinical trials and advancements in the company's pipeline, attracting investor interest.

Portfolio Pulse from Benzinga Newsdesk

November 27, 2023 | 2:46 pm

GDC

LIZI

MOMO

TEO

Benzinga Insights has identified five value stocks in the communication services sector based on their low P/E ratios, suggesting they may be undervalued. The stocks are GD Culture Group (GDC), Lizhi (LIZI), Scienjoy Holding (SJ), Telecom Argentina (TEO), and Hello Gr (MOMO). The article provides recent earnings per share (EPS) data, indicating mixed performance with some companies experiencing decreases in EPS while others have seen increases.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 2:44 pm

FWBI

KPRX

OGN

TXMD

VYGR

Benzinga Insights has identified notable value stocks in the healthcare sector based on low P/E multiples. First Wave BioPharma (FWBI), Kiora Pharmaceuticals (KPRX), TherapeuticsMD (TXMD), Voyager Therapeutics (VYGR), and Organon (OGN) are highlighted as undervalued. FWBI, KPRX, and VYGR reported decreased earnings per share in their latest quarters, while TXMD saw an increase, and OGN experienced a decrease but also reported a higher dividend yield.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 2:43 pm

Smart Share Global Ltd (NASDAQ:EM) reported a 24.7% year-on-year decline in Q3 FY23 sales to $84.08 million, primarily due to a decrease in mobile device charging revenues. The company's mobile device charging revenues fell 30.3% to $77.3 million. General and administrative expenses increased by 26.1% to $5.1 million, while operating income was $4.7 million. Smart Share Global had $455.0 million in cash and equivalents and saw an increase in service availability and registered users. However, adjusted earnings per ADS of $0.03 missed the consensus estimate of $0.10, and shares traded lower by 0.65% at $0.7450.

Portfolio Pulse from Shivani Kumaresan

November 27, 2023 | 2:39 pm